Nicole Canfora Lupo
Advertisement
Articles by Nicole Canfora Lupo
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
Rezatapopt Shows 46% ORR in TP53 Y220C–Mutated Ovarian Cancer
2
First-Line Savolitinib/Osimertinib Improves PFS in MET+ NSCLC
3
FDA Approval Sought for Selinexor Plus Ruxolitinib in Myelofibrosis
4
FDA Type C Meeting Supports Phase 3 Design for DLL3-Targeted ADC in ES-SCLC
5